NATCO Pharma Ltd.
Share Price Target & Analysis

NSE:NATCOPHARM

787.73

VWAP

785

Open

785.15

Close

797.45

High

778

Low

1226.8

52 Week High

791.85 ⇧
6.70 (0.85%)

NATCOPHARM

(PHARMA)
4% Momentum

Watch Carefully

773.6

52 Week Low

82.14

EPS

17.41

PE

1.57

PB

Deluxe
Quality

Steel
Valuation

#Analysis

NSE: NATCOPHARM Share Price Financial Analysis & Valuation

NATCO Pharma Ltd. (NATCOPHARM) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Small Cap company with Market Capitalization of Rs 16084.6 (in Cr). Total number of free float shares are 18.2 (in Lacs). NATCO Pharma Ltd. is listed on NSE with Exchange ID - INE987B01026 and trading code is NSE:NATCOPHARM with short name Natco Pharma.

In the past 1 year, NATCO Pharma Ltd. has declared an equity dividend of Rs 0.63 per share. At the current share price of NATCOPHARM at Rs 791.85, this results in a dividend yield of 0.08 %.

As per the Fundamental Analysis of NSE:NATCOPHARM, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine NATCOPHARM underlying value and future prospects. All of this data is available in NATCOPHARM financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:NATCOPHARM, it is clearly understood that NATCOPHARM is Deluxe performer in terms of earnings and profit margins with an EPS of 82.14. NSE:NATCOPHARM book value per share as of today is 505. The current price to book ratio for NATCOPHARM as of Oct 23, 2026 is 1.57.

Valuation of the Stock: The current valuation of NATCOPHARM stock is like Steel which means currently the stock is Moderately Priced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of NATCOPHARM whether to BUY this stock at current valuation. The delivery percentage of NATCOPHARM is 447174% is very crucial parameter which shows that 447174% investors are anticipating that the price of NATCOPHARM share should go up with VWAP at 787.73.

Now, the main question is whether to BUY or SELL, NSE:NATCOPHARM at current valuation.
As per latest Analysis No. #4518:-

⇑ STRONG BUY NATCOPHARM if All Greens

⇗ BUY NATCOPHARM (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD NATCOPHARM (With Stop Loss) if only 1 Green

⇘ SELL NATCOPHARM if NO Green Indicator

NSE: NATCOPHARM Share Price Today (Oct 23, 2026)

(NATCO Pharma Ltd. Daily Analysis on the basis of NATCOPHARM Intraday Graph & Trend)

NATCO Pharma Ltd. share price moved Up by 0.85% from its previous close of Rs 785.15. NATCOPHARM stock last traded price is 791.85. NATCOPHARM share price trend is Up with a total of 569535 stocks traded till now. It has touched an intraday high of Rs 797.45 and an intraday low of Rs 778. The NATCOPHARM trading at 791.85, Up by Rs. 6.70, or 0.85 percent which suggests that most of the Traders are anticipating that the price of NATCOPHARM share should go Up.

NSE: NATCOPHARM Share Price Tomorrow Prediction

(NATCO Pharma Ltd. Share Price Prediction for Tomorrow & future forecast is based on Current Trend of NATCOPHARM)

NATCO Pharma Ltd. share price moved Up by 0.85%. NATCOPHARM share price short term trend is Up. It suggests that NATCOPHARM Share Price for Tomorrow remains the same with VWAP at 787.73 will be treated as stop loss for intraday traders. NATCO Pharma Ltd. Long term investors can follow the NATCOPHARM long term trend as mentiond in future forecast table.

NSE Code

NSE: NATCOPHARM

NATCOPHARM Share Price Today

 791.85

NATCOPHARM Share Price Target Prediction for 2026 ^

 811 - 1061.6

NATCOPHARM Share Price Target Prediction for 2027*^

 1061.6 - 1313.4

NATCOPHARM Share Price Target Prediction for 2028*^

 1313.4 - 1405.3

NATCOPHARM Share Price Target Prediction for 2029*^

 1476

NATCOPHARM Share Price Target Prediction for 2030*^

 1518

NATCOPHARM Share Price Target Prediction for 2035*^

 1654
NATCOPHARM Current Book Value
502.5

*NATCO Pharma Ltd. Short Term & Long Term share price target is based on current financial year earings of the company.
^NATCOPHARM share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

NATCOPHARM Technical Analysis

Candlestick Pattern: @826.3

NATCOPHARM Moving Averages

BUY (0) NEUTRAL (0) SELL (14)
MA Simple Action S1 Expo Action E2
MA_5 831.46 SELL 832.16 SELL
MA_12 847.41 SELL 847.78 SELL
MA_20 865.3 SELL 860.37 SELL
MA_32 887.89 SELL 880.16 SELL
MA_50 909.61 SELL 897.75 SELL
MA_100 953.65 SELL 923.39 SELL
MA_200 945.67 SELL 946.29 SELL

NATCOPHARM Trend Oscillators

BUY (0) NEUTRAL (1) SELL (3)
Trend Oscillators Value Action
Bollinger Bands 865.3 Downtrend
MACD -2.01 SELL
ADX 17.29 NO or Weak Trend
DMI (+/-) 11.47 / 21.5 Downtrend

NATCOPHARM Momentum Oscillators

BUY (2) NEUTRAL (6) SELL (4)
Momentum Oscillators Value Action
RSI 31.4 Neutral
STOCHASTIC_K (Fast) 26.78 Neutral
STOCHASTIC_D (Slow) 23.53 Neutral
CCI -106.81 SELL
PSAR 853.42 SELL
TRUE RANGE 23.7 BUY
ATR 22.22 BUY
WILLIAMS R -86.91 Oversold
TRIX 0 Neutral
STOCHASTIC RSI K 44.31 Neutral
STOCHASTIC RSI D 60.93 Neutral
MOMENTUM -80.7 SELL

NATCOPHARM Last 1 Year Trend

Duration Value
1 Year -3.42%
3 Months -4.47%
1 Month -8.9%
1 Week -2.01%

NATCOPHARM Technical Analysis Summary

Updated on 2026-09-09
Action Overall (%)
BUY 7%
NEUTRAL / HOLD 23%
SELL 70%

(powered by Zerodha)

Most popular Questions & Answers about NATCOPHARM

NATCO Pharma Ltd. Frequently Asked Questions (FAQs)

NATCO Pharma Ltd. stock last traded price is 791.85. NATCOPHARM share price moved Up by 0.85% from its previous close of Rs 785.15.

NATCO Pharma Ltd. share price trend is Up with a total of 569535 stocks traded till now. It has touched an intraday high of Rs 1239.068 and an intraday low of Rs 778. The NATCOPHARM trading at 791.85, Up by Rs. 6.70, or 0.85 percent which suggests that most of the Traders are anticipating that the price of NATCOPHARM share should go Up and the Stop Loss will be around 787.73.

The market cap of NATCO Pharma Ltd. is ₹16084.6 (in Cr) as of Oct 22, 2026.

The current price to earning ratio for NATCO Pharma Ltd. as of Oct 22, 2026 is 17.41.

The current price to book ratio for NATCO Pharma Ltd. as of Oct 22, 2026 is 1.57.

The highest price of NATCO Pharma Ltd. stock is ₹1226.8 in the last 52-week.

The lowest price of NATCO Pharma Ltd. stock is ₹773.6 in the last 52-week.

NATCO Pharma Ltd. share trading at ₹791.85, Up by Rs. 6.70, or 0.85 percent which suggests that most of the traders are anticipating that the price of NATCOPHARM share should go Up.

In 2026, Stock price target for NATCO Pharma Ltd. (NATCOPHARM) will be around ₹811 on downside and ₹1061.6 on upside. NATCO Pharma Ltd. share price target is based on current financial year earings of the company.

In 2027, Stock price target for NATCO Pharma Ltd. (NATCOPHARM) will be around ₹1061.6 on downside and ₹1313.4 on upside. NATCO Pharma Ltd. share price target is based on forecasted future earnings of the company.

In 2028, Stock price target for NATCO Pharma Ltd. (NATCOPHARM) will be around ₹1313.4 on downside and ₹1405.3 on upside. NATCO Pharma Ltd. share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for NATCO Pharma Ltd. (NATCOPHARM) will be around ₹1518 NATCO Pharma Ltd. share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of NATCOPHARM.

The price of NATCO Pharma Ltd. (NATCOPHARM) shares moved by 0.85%. The short-term trend for NATCOPHARM share price is Up. It implies that the share price of NATCOPHARM will stay the same tomorrow and that intraday traders should treat VWAP at 787.73 as a stop loss. Investors with a long-term outlook can track NATCOPHARM long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of NATCOPHARM stock is 984.9. Compared to the current market price of 791.85 INR, the NATCOPHARM stock is Undervalued by 19.6%.

As per the fundamental analysis of NATCO Pharma Ltd. (NATCOPHARM), it is of Deluxe quality in terms of earnings and profit margins with an EPS of 82.14. NATCO Pharma Ltd. book value per share as of today is 505. The current price to book ratio for NATCOPHARM as of Oct 23, 2026 is 1.57.


NSE:NATCOPHARM News & Other Useful Information about NATCOPHARM Share Price


Peer Comparison of NSE: NATCOPHARM

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1748.00 16.35 97.89
DIVISLAB 8950.00 115.55 663.06
MEDICAMEQ 253.35 12.15 208.08
CIPLA 1338.00 51.67 434.02
DRREDDY 1229.50 53.19 380.63
TORNTPHARM 4524.40 87.32 235.7
BIOCON 323.50 1.27 166.51
LUPIN 1928.90 154.86 718.33
ALKEM 4947.00 212.33 1218.48
AUROPHARMA 1571.70 46.49 403.84
ABBOTINDIA 25030.00 766.11 2448.41
GLAXO 2404.70 63.65 147.25
IPCALAB 1953.30 56.72 329.23
LAURUSLABS 1970.00 20.74 102.57
LALPATHLAB 1838.20 39.68 157.23
PFIZER 3612.30 170.54 963.41
AJANTPHARM 3283.90 89.3 363.23
SANOFI 2772.80 158.05 332.96
NATCOPHARM 791.85 82.14 505
APLLTD 760.10 48.4 295.69
JBCHEPHARM 2408.90 54.16 251.48
GLENMARK 2166.60 1.24 881.78
AAREYDRUGS 106.73 2.39 53.38
JUBLPHARMA 938.30 4.35 145.63
SPARC 171.77 48.14 40.45
GRANULES 794.75 23.25 180.42
ASTRAZEN 5988.50 86.44 364.29
CAPLIPOINT 2222.00 55.52 285.6
FDC 338.70 21.19 161.21
HIKAL 193.65 9.34 96.63
Updated at: 2026-10-23 15:57:34

Feel free to contact us, in case of any queries.

Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 2477.00 -73.00 (-2.86%) | ADANIPORTS 1702.70 -47.30 (-2.7%) | APOLLOHOSP 7730.00 125.50 (1.65%) | ASIANPAINT 2307.00 22.20 (0.97%) | AXISBANK 1217.50 5.50 (0.45%) | BAJAJ-AUTO 10072.00 -83.00 (-0.82%) | BAJAJFINSV 1655.00 -23.00 (-1.37%) | BAJFINANCE 928.95 -13.15 (-1.4%) | BEL 362.00 -2.50 (-0.69%) | BHARTIARTL 1892.10 -2.90 (-0.15%) | CIPLA 1338.00 7.10 (0.53%) | COALINDIA 397.45 -5.10 (-1.27%) | DRREDDY 1229.50 -9.50 (-0.77%) | EICHERMOT 7066.00 -18.50 (-0.26%) | GRASIM 2894.00 -0.40 (-0.01%) | HCLTECH 1422.20 0.50 (0.04%) | HDFCBANK 692.80 -1.25 (-0.18%) | HDFCLIFE 523.75 -4.60 (-0.87%) | HINDALCO 869.85 -15.75 (-1.78%) | HINDUNILVR 1814.70 -13.60 (-0.74%) | ICICIBANK 1394.20 -4.30 (-0.31%) | INDIGO 4549.00 -51.00 (-1.11%) | INFY 1153.80 0.45 (0.04%) | ITC 257.90 -1.00 (-0.39%) | JIOFIN 205.03 -5.77 (-2.74%) | JSWSTEEL 1185.50 -34.50 (-2.83%) | KOTAKBANK 430.50 -6.50 (-1.49%) | LT 3647.00 8.70 (0.24%) | M&M 2861.20 -2.90 (-0.1%) | MARUTI 11230.00 60.00 (0.54%) | MAXHEALTH 815.00 -2.00 (-0.24%) | NESTLEIND 1175.00 -14.90 (-1.25%) | NTPC 298.00 -4.60 (-1.52%) | ONGC 227.50 2.50 (1.11%) | POWERGRID 247.40 -1.00 (-0.4%) | RELIANCE 1190.00 5.50 (0.46%) | SBILIFE 1640.00 -2.90 (-0.18%) | SBIN 958.60 -11.40 (-1.18%) | SUNPHARMA 1748.00 -10.00 (-0.57%) | TATACONSUM 963.90 4.10 (0.43%) | TATASTEEL 167.67 -4.66 (-2.7%) | TCS 2530.00 23.10 (0.92%) | TECHM 1790.00 -39.10 (-2.14%) | TITAN 4299.70 -50.30 (-1.16%) | TMPV 264.60 -5.40 (-2%) | TRENT 2727.50 -48.30 (-1.74%) | ULTRACEMCO 11050.00 92.00 (0.84%) | WIPRO 189.84 -0.57 (-0.3%) |
Top